With its broad base of expertise, the mission of the Georgia Center for Diabetes Translation Research (GCDTR) is to facilitate and grow Type 2 translation research in diabetes within the state of Georgia. Type 2 translation is defined as research focused on translating approaches that have clearly demonstrated efficacy into real world health care settings, and communities, at risk with an emphasis on reach, sustainability, and widespread implementation.
Current Funding Opportunities
Pilot Grant Program
GCDTR is seeking pilot grant proposals in the field of diabetes translation research that advances health equity. Faculty researchers from Emory University, Morehouse School of Medicine, and Georgia Institute of Technology are eligible to apply. Two levels of funding are available:
- Preliminary or formative research: This opportunity is for exploratory, feasibility, and formative diabetes health equity studies to generate preliminary data to facilitate a subsequent submission of a research grant for external funding. Examples include, but are not limited to, qualitative field work, community-engaged research for development of research questions, instrument, or assay testing, and secondary data analyses that leverage existing databases for data science, analytics, and modeling. Budget: up to $30,000 for one year.
- Prospective clinical or community-based studies: This opportunity is for pilot studies addressing diabetes health equity questions using prospective approaches in clinical or community-based settings to create or strengthen preliminary data to facilitate subsequent external grant submissions. A variety of methods may be used, including social, behavioral, clinical and community concepts, evaluations of clinical or innovative interventions, and dissemination and implementation studies. Budget: up to $50,000 for one year.
Letter of intent due: January 22, 2002
Application deadline: April 1, 2022
For more infomation, click here.
Micro Grant Rapid Funding Mechanism
The Georgia Center for Diabetes Translation Research (GCDTR) is pleased to announce a Micro Grant Rapid Funding Mechanism (MGRFM). This is a unique competitive opportunity being offered by the GCDTR to provide timely and critical resources that can be leveraged by investigators for the submission of larger research funding requests. Award amounts will range from $500 to $2,000. The MGRFM grants will support diabetes translation research leading to the submission of an NIH (preferably) or other extramural research funding application that addresses themes encompassed in GCDTR’s research cores (www.gcdtr.org/core-programs/).
Funds are intended to be used to:
- Enable a new NIH or other extramural application that is expected to be submitted within the next 6 to 12 months
- Gather data needed for a scored NIH or other extramural application that is currently being revised for resubmission
Incidence and Pathophysiology of Diabetes in South Asian Adults Living in India and Pakistan Compared with US blacks and Whites
Narayan KMV, Kondal D, Kobes S, Staimez LR, Mohan D, Gujral UP, Patel SA, Anjana RM, Shivashankar R, Ali MK, Chang HH, Kadir M, Prabhakaran D, Daya N, Selvin E, Tandon N, Hanson R, Mohan V.
BMJ Open Diabetes Research & Care - 2021;9:3001988.
South Asians (SA) and Pima Indians have high prevalence of diabetes but differ markedly in body size. The pathophysiology of type 2 diabetes in non-obese South Asians may imply the need to investigate strategies at improving insulin secretion for diabetes prevention.
Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks
Unjali P. Gujral, Leslie Johnson, Jannie Nielsen, Priyathama Vellanki, J. Sonya Haw, Georgia M. Davis, Mary Beth Weber, Francisco J. Pasquel
BMJ Open Diabetes Research & Care - 2020 Jul;8(1):e001520.
The authors describe how to respond to the public health crisis focused on diabetes care in the USA. They present strategies to address and evaluate transitions in diabetes care occurring in the immediate short-term (ie, response and mitigation), as well as phases to adapt and enhance diabetes care during the months and years to come while also preparing for future pandemics (ie, recovery, surveillance, and preparedness).
Rodolfo J. Galindo, Grazia Aleppo, David C. Klonoff, Elias K. Spanakis, Shivani Agarwal, Priya Vellanki, Darin E. Olson, Guillermo E. Umpierrez, Georgia M. Davis, Francisco J. Pasquel
Journal of Diabetes Science and Technology - 2020 Jul;14(4):822-832.
In this commentary, the authors analyze the answers to six questions about what is needed to bring CGM into the hospital as a reliable, safe, and effective tool, especially with regard to those patients with COVID-19.
DIABETES PREVENTION WORKING GROUP
Are you interested in diabetes prevention research? Researchers at Emory are forming a working group to provide support and discussion around diabetes prevention and diabetes prevention research. This group will convene monthly to:
- Provide a platform for members to present current ideas, on-going research, and research presentations for peer feedback
- Discuss new findings in diabetes prevention research
- Allow opportunities for networking and forming new collaborations
If you are interested in joining us or for more information, please email Dr. Mary Beth Weber at email@example.com.
COVID-19 HEALTH EQUITY DASHBOARD
To track and respond to this differential health impact, EGDRC, under the direction of Shivani Patel, has developed a COVID-19 Health Equity Dashboard (https://covid19.emory.edu). This is a dynamic and interactive web-based dashboard to visualize the interplay between social determinants and COVID-19 epidemiologic metrics at the county level. The dashboard was designed to be a public-facing tool that curates, disseminates and ultimately synthesizes actionable information to guide localized response to the epidemic over time. Current functionality allows users to quickly compare each county’s COVID-19 cases, deaths, and social characteristics to the state and national average; visualize the relationship between social determinants and COVID-19 outcomes; view a printer-friendly report of detailed county data; and create side-by-side maps comparing key metrics at the county level. View